ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2465

Cytokine Profile Comparison of Monogenic and Complex Conditions with Interferon-Regulated Gene Signatures in Chronic Atypical Neutrophilic Dermatosis with Lipodsytrophy and Elevated Temperature (CANDLE), SAVI, Aicardi-Goutieres Syndrome, JDM, and SLE

Hanna Kim1, Yin Liu2, Adriana Almeida de Jesus1, Robert Wesley3, Yan Huang1, Gina A. Montealegre Sanchez1, Dawn C. Chapelle1, Wanxia L. Tsai4, Massimo G. Gadina4, Frederick W. Miller5, Sarfaraz Hasni6, Adeline Vanderver7, Lisa G Rider5 and Raphaela Goldbach-Mansky1, 1Translational Autoinflammatory Diseases Section, NIAMS, NIH, Bethesda, MD, 2Scientific Review Branch, NIAMS, NIH, Bethesda, MD, 3Clinical Center, National Institutes of Health, Bethesda, MD, 4Translational Immunology Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, 5Environmental Autoimmunity Group, NIEHS, NIH, Bethesda, MD, 6National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 7Pediatric Neurology, Children's National Medical Center, Washington, DC

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: autoimmune diseases, Autoinflammatory Disease, cytokines, interferons and pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Pediatric Rheumatology - Pathogenesis and Genetics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

An
Interferon (IFN) Regulated Gene Signature (IRS) was previously reported in patients
with two complex autoimmune diseases, juvenile systemic lupus (JSLE)1
 and juvenile dermatomyositis (JDM).2 Recently, three Mendelian conditions
including CANDLE syndrome3, STimulator of IFN Genes or STING-associated Vasculopathy with
onset during Infancy (SAVI)4, and Aicardi Goutieres syndrome (AGS)5
have demonstrated a prominent IRS.  Previous evaluations6 found
clinical phenotypic overlap such as basal ganglia calcifications (CANDLE, AGS),
lipodystrophy (CANDLE, JDM), and myositis (JDM, CANDLE, SLE) raising interest
in a shared role of IFN in disease-pathogenesis.  This study aims to assess cytokine
profile differences between IFN conditions, healthy controls and the IL-1
mediated monogenic disease, NOMID, to better understand pathogenesis and identify
potential disease-specific biomarkers. 

Methods:

Plasma/serum
cytokine levels of 6 cytokines identified by literature review and preliminary
analysis6 were measured in 5 IFN conditions (3 Mendelian and 2
complex), the IL-1 mediated disease, NOMID, and healthy
controls using a multiplex bead -based assay (Luminex/Austin, TX).  Analysis of
variance (ANOVA) followed by Dunnett’s tests were performed to identify
significant differences between each IFN condition and: 1) healthy controls and
2) NOMID (IL-1 mediated disease control).  ANOVA, followed by Student-Newman-Keuls
post-hoc tests, were used to assess for significant differences among the 5 IFN
conditions.  Statistical analysis done with Stata 12 (College Station, TX).

Results:

All
significant values are higher in an IFN condition than NOMID or healthy
controls, except RANTES which is lower in AGS versus NOMID.  Most significantly
elevated are IP-10 in CANDLE and SAVI, and MIP1-alpha in SLE compared to healthy
controls and NOMID.  Among the 5 IFN conditions, IP-10 is significantly higher
in CANDLE and SAVI versus AGS, JDM, and SLE.  RANTES is significantly lower in
AGS versus the 4 other IFN conditions. 

Conclusion:

The IFN
inducible chemokine, IP-10/CXCL10, is significantly elevated in CANDLE and SAVI,
even compared to AGS, JDM, SLE, and NOMID suggesting IFN-driven systemic inflammation
in CANDLE and SAVI.  The monocyte migration factor MCP-1/CCL2 is similarly induced
in IFN diseases and the IL-1 disease, NOMID, consistent with its role in routine
immunological surveillance observed in a variety of inflammatory conditions.  Significant
and specific elevation of MIP1-alpha may play a role in granulocyte recruitment
and activation in SLE.  Distinct cytokine profiles in IFN and IL-1 mediated
diseases may help in understanding organ-specific inflammatory pathogenesis and
development of disease-specific biomarkers.

1Bennett, Exp Med, 2003,2Baechler, Mol Med,
2007, 3 Liu,  A&R, 2012, 4Liu, NEJM,
2014, 5 Rice, Nat Gen, 2012 6 Kim, H. A&R,
2013

 


Disclosure: H. Kim, None; Y. Liu, None; A. Almeida de Jesus, None; R. Wesley, None; Y. Huang, None; G. A. Montealegre Sanchez, None; D. C. Chapelle, None; W. L. Tsai, None; M. G. Gadina, None; F. W. Miller, None; S. Hasni, None; A. Vanderver, None; L. G. Rider, None; R. Goldbach-Mansky, None.

To cite this abstract in AMA style:

Kim H, Liu Y, Almeida de Jesus A, Wesley R, Huang Y, Montealegre Sanchez GA, Chapelle DC, Tsai WL, Gadina MG, Miller FW, Hasni S, Vanderver A, Rider LG, Goldbach-Mansky R. Cytokine Profile Comparison of Monogenic and Complex Conditions with Interferon-Regulated Gene Signatures in Chronic Atypical Neutrophilic Dermatosis with Lipodsytrophy and Elevated Temperature (CANDLE), SAVI, Aicardi-Goutieres Syndrome, JDM, and SLE [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/cytokine-profile-comparison-of-monogenic-and-complex-conditions-with-interferon-regulated-gene-signatures-in-chronic-atypical-neutrophilic-dermatosis-with-lipodsytrophy-and-elevated-temperature-candl/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cytokine-profile-comparison-of-monogenic-and-complex-conditions-with-interferon-regulated-gene-signatures-in-chronic-atypical-neutrophilic-dermatosis-with-lipodsytrophy-and-elevated-temperature-candl/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology